A ‘Holy Grail’ Sleep Apnea Pill Could Be On The Market Next Year

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

AI 50 2026: Submissions For Forbes’ List Of The Top 50 AI Startups Is Open

Forbes’ eighth annual AI 50 list, featuring the most prominent AI startups, is accepting submissions until February 6, 2026.

AI Didn’t ‘Unmask’ The Minneapolis ICE Shooter — It Invented A Face

Viral AI images after the MInneapolis ICE shooting show how easily fabricated faces can masquerade as evidence —and why that confusion is dangerous.

Nvidia And This Bill Gates-Backed Startup Are Building Fusion Power With AI

In this week’s edition of The Prototype, we look at building a virtual fusion power plant, a major quantum breakthrough, AI for drug discovery and more.

Midas List 2026: Submissions Open To Rank The World’s Leading Venture Capitalists

The definitive ranking of the 100 best tech investors in the world, the Forbes Midas List is now seeking submissions for its landmark 25th annual edition through January 23rd.

Why Prediction Markets Need Insider Trading

An outcry over insider trading erupted after one Polymarket user made $400,000 betting that Maduro would be ousted, hours before it happened. Here’s why the godfather of prediction markets thinks it’s a good thing.

Founder Of Chinese AI Model Developer MiniMax Becomes A Billionaire As Shares Surge On Listing

Yan Junjie, the 36-year-old chairman and CEO of MiniMax, now boasts a net worth of $3.2 billion after the AI model developer’s $618 million Hong Kong IPO.

This CEO’s $1.7 Billion Health Startup Began With Moms. Now She Wants To Expand To All Women.

Former Flatiron Health exec Marta Bralic Kerns raised $92 million to expand her virtual care model to women at all stages of their lives.

Chinese OpenAI Challenger Zhipu’s IPO Mints New Billionaire

Zhipu, which operates a ChatGPT-like service called Z.ai, raised $558 million in the IPO. Its chairman, Liu Debing, amassed a fortune of $2.1 billion based on his stake in the Chinese AI model company.

Measles And Flu Hit New Highs As Trump Administration Hammers Vaccines

In this week’s edition of InnovationRx, we look at a former Wall Street analyst’s $4 billion obesity drug company, Wegovy’s weight-loss pill, and more.